CANada in the INCremental dialysis to improve Health outcomes in people starting Hemodialysis (CAN INCH-HD) study: a randomized controlled trial

加拿大开展增量透析以改善开始血液透析患者的健康结果 (CAN INCH-HD) 研究：一项随机对照试验

• 批准号: 452633
• 负责人: Lok Charmaine E
• 金额: $ 47.65万
• 依托单位: University Health Network (Toronto)
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2021
• 资助国家: 加拿大
• 起止时间: 2021-09-01 至 2026-09-01
• 项目状态: 未结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=452633&lang=en
• 关键词: Dialysis Initiation; Frequency Of Dialysis; Health Economics; Kidney Failure; Patient Engagement; Quality Of Life; Safety

Most patients in the developed world with kidney failure start dialysis with thrice weekly hemodialysis (HD). Although the most common treatment for kidney failure, HD continues to be associated with drastically reduced quality of life (QoL <60% of full h

在发达国家，大多数肾衰竭患者开始透析时每周进行三次血液透析（HD）。尽管HD是肾衰竭最常见的治疗方法，但它仍与生活质量的急剧下降有关（QoL <全h的60%）。